Safety information for antipsychotic drug Abilify and risk of certain impulse-control
behaviours https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/55668a-fra.php 2015 false false false Canada French English pharmacovigilance note Disruptive, Impulse Control, and Conduct Disorders antipsychotic agents aripiprazole schizophrenia bipolar disorder patients guideline administration, oral injections, intramuscular Pathological Gambling hypersexuality state risk Aripiprazole